Schweitzer Fachinformationen
Wenn es um professionelles Wissen geht, ist Schweitzer Fachinformationen wegweisend. Kunden aus Recht und Beratung sowie Unternehmen, öffentliche Verwaltungen und Bibliotheken erhalten komplette Lösungen zum Beschaffen, Verwalten und Nutzen von digitalen und gedruckten Medien.
Preface ix
List of Contributors xi
1 An Introduction to Molecular Imaging 1 Ga-Lai Law and Wing-Tak Wong
1.1 Introduction 1
1.2 What is Positron Emission Tomography (PET)? 3
1.3 What is Single Photon Emission Computed Tomography (SPECT)? 6
1.4 What is Computed Tomography (CT) or Computed Axial Tomography (CAT)? 8
1.5 What is Magnetic Resonance Imaging (MRI)? 11
1.6 What is Optical Imaging? 15
1.7 What is Ultrasound (US)? 19
1.8 Conclusions 22
References 24
2 Chemical Methodology for Labelling and Bioconjugation 25 Lina Cui and Jianghong Rao
2.1 Introduction 25
2.2 Chemical Methods 25
2.3 Site-Specific Modification of Proteins or Peptides 36
2.4 Conclusions 45
References 45
3 Recent Developments in the Chemistry of [18F]Fluoride for PET 55 Dirk Roeda and Frédéric Dollé
3.1 Introduction 55
3.2 Fluorine-18: The Starting Material 56
3.3 Reactive [18F]Fluoride 56
3.4 The Radiofluorination 58
3.5 Labelling of Large Biological Molecules 65
3.6 Conclusions 70
References 70
4 Carbon-11 Nitrogen-13 and Oxygen-15 Chemistry: An Introduction to Chemistry with Short-Lived Radioisotopes 79 Philip W. Miller Koichi Kato and Bengt Långström
4.1 Introduction 79
4.2 Carbon-11 Chemistry 81
4.3 Nitrogen-13 Chemistry 93
4.4 Oxygen-15 Chemistry 98
4.5 Conclusions 99
References 99
5 The Chemistry of Inorganic Nuclides (86Y 68Ga 64Cu 89Zr 124I) 105 Eric W. Price and Chris Orvig
5.1 Introduction: Inorganic Nuclide-Based Radiopharmaceuticals 105
5.2 Radiopharmaceutical Design 107
5.3 Radiopharmaceutical Stability 108
5.4 86Yttrium Radiometal Ion Properties 110
5.5 68Gallium Radiometal Ion Properties 116
5.6 64Copper Radiometal Ion Properties 120
5.7 89Zirconium Radiometal Ion Properties 123
5.8 124Iodine Nuclide Properties 125
5.9 Conclusions 129
References 129
6 The Radiopharmaceutical Chemistry of Technetium and Rhenium 137 Jonathan R. Dilworth and Sofia I. Pascu
6.1 Introduction 137
6.2 Technetium and Rhenium Radiopharmaceutical Chemistry 139
6.3 Technetium and Rhenium(IV) 149
6.4 Technetium and Rhenium(III) 149
6.5 Technetium and Rhenium(I) 151
6.6 Imaging of Hypoxia with 99mTc 155
6.7 Technetium and Rhenium Diphosphonate Complexes 157
6.8 The Future for Technetium and Rhenium Radiopharmaceuticals 157
References 158
7 The Radiopharmaceutical Chemistry of Gallium(III) and Indium(III) for SPECT Imaging 165 Jonathan R. Dilworth and Sofia I. Pascu
7.1 Introduction to Gallium and Indium Chemistry 165
7.2 Gallium and Indium Complexes and Related Bioconjugates 166
7.3 Auger Electron Therapy with 111Indium 175
7.4 Prospects for 67Ga and 111In Radiochemistry 176
References 176
8 The Chemistry of Lanthanide MRI Contrast Agents 179 Stephen Faulkner and Octavia A. Blackburn
8.1 Introduction 179
8.2 Gadolinium Complexes as MRI Contrast Agents 180
8.3 Minimising the Toxicity of Gadolinium Contrast Agents 184
8.4 Rationalising the Behaviour of MRI Contrast Agents 185
8.5 Strategies for Increasing Relaxivity 188
8.6 Responsive MRI 192
8.7 Conclusions and Prospects 195
References 195
9 Nanoparticulate MRI Contrast Agents 199 Juan Gallo and Nicholas J. Long
9.1 Introduction 199
9.2 T2 Contrast Agents 200
9.3 T1 Contrast Agents 203
9.4 T1-T2 Dual MRI Contrast Agents 208
9.5 Water Solubilisation 209
9.6 Functionalisation and Surface Modification 213
9.7 Applications 216
9.8 Conclusions and Outlook 220
References 220
10 CEST and PARACEST Agents for Molecular Imaging 225 Osasere M. Evbuomwan Enzo Terreno Silvio Aime and A. Dean Sherry
10.1 Introduction 225
10.2 Diamagnetic CEST Agents 226
10.3 Paramagnetic Chemical Exchange Saturation Transfer (PARACEST) Agents 229
10.4 Responsive PARACEST Agents 230
10.5 In Vivo Detection of PARACEST Agents 233
10.6 Supramolecular CEST Agents 235
10.7 LipoCEST Agents 236
10.8 Conclusions 241
References 241
11 Organic Molecules for Optical Imaging 245 Michael Hon-Wah Lam Ga-Lai Law Chi-Sing Lee and Ka-Leung Wong
11.1 Introduction 245
11.2 Designing Molecular Probes for Bio-imaging 246
11.3 Different Types of Organic-based Chromophores and Fluorophores for Bioimaging 249
11.4 Mechanisms of Photophysical Processes and Their Applications in Molecular Imaging and Chemosensing 258
11.5 Two/Multi-photon Induced Emission and In Vitro / In Vivo Imaging 262
11.6 Time-Resolved Imaging 266
11.7 Bioluminescence in Molecular Imaging 267
11.8 Photoacoustic Imaging 269
11.9 Conclusion and Future Perspectives 270
References 270
12 Application of d- and f-Block Fluorescent Cell Imaging Agents 275 Michael P. Coogan and Simon J. A. Pope
Abbreviations 275
12.1 Introduction 275
12.2 d6 Metal Complexes in Fluorescent Cell Imaging 277
12.3 f-Block Imaging Agents 285
12.4 Conclusions 296
References 296
13 Lanthanide-Based Upconversion Nanophosphors for Bioimaging 299 Fuyou Li Wei Feng Jing Zhou and Yun Sun
13.1 Introduction 299
13.2 Fabrication of Ln-UCNPs Suitable for Bioimaging 299
13.3 Surface Modification of Ln-UCNPs 304
13.4 In Vivo Imaging Applications 306
13.5 Biodistribution and Toxicity of UCNPs 316
13.6 Future Directions 317
References 317
14 Microbubbles: Contrast Agents for Ultrasound and MRI 321 April M. Chow and Ed X. Wu
14.1 Introduction 321
14.2 Classification of Microbubbles 321
14.3 Applications in Ultrasound Imaging 324
14.4 Applications in Magnetic Resonance Imaging 327
14.5 Applications beyond US Imaging and MRI 330
14.6 Conclusions: Limitations Bioeffects and Safety 330
References 331
15 Non-Nanoparticle-Based Dual-Modality Imaging Agents 335 Reinier Hernandez Tapas R. Nayak Hao Hong and Weibo Cai
15.1 Introduction 335
15.2 PET/Optical Agents 336
15.3 SPECT/Optical Agents 341
15.4 MRI/Optical Agents 345
15.5 PET/MRI Agents 348
15.6 Conclusions 348
References 350
16 Chemical Strategies for the Development of Multimodal Imaging Probes Using Nanoparticles 355 Amanda L. Eckermann Daniel J. Mastarone and Thomas J. Meade
16.1 Introduction 355
16.2 Fluorescence-MRI 357
16.3 Near-Infrared Fluorescence/MRI 359
16.4 NIR-PET 368
16.5 Upconversion Luminescence 372
16.6 PET-SPECT-CT-MRI 376
16.7 Ultrasound 382
16.8 Magnetomotive Optical Coherence Tomography (MM-OCT) 383
16.9 Photoacoustic Imaging 384
16.10 Conclusions 384
References 385
Index 389
Ga-Lai Law and Wing-Tak Wong
Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China
The aim of this book is to introduce the concepts of different imaging techniques that are employed for diagnostics and therapy and the role that chemistry has played in their evolution. The book provides a general introduction to the area of molecular imaging, giving an account of the role of molecular design and its importance in modern-day techniques, with an in-depth introduction of some of the probes and methodologies employed. This first chapter introduces the different types of imaging modalities currently at the forefront of imaging and illustrates some basic concepts underlying these techniques. It acts as a simplified background to set the scene for the following chapters, which will discuss the chemical properties of molecules and the role they play in different imaging modalities. For the interested readers, other textbooks are referenced that will provide more detailed information regarding the different techniques reviewed.
In life everything is incessantly changing. There is constant evolution in life sciences, evolution in the way problems arise, and evolution in the way they are solved. Diagnostics and therapy are both important, but as Einstein said, "intellectuals solve problems, geniuses prevent them." The key challenge still remains to unravel the hidden knowledge within life sciences, which constantly challenges us with new diseases and mechanistic mutation of biological systems and pathways [1]. Again, as stated by Einstein, "once we accept our limits, we go beyond them."
Molecular imaging aims to detect and monitor mechanistic processes in cells, tissues, or living organisms with the use of instruments and contrast mechanisms without perturbing their living system. Ultimately, it is a field that utilises molecular building blocks to bring solutions to problems by specialised imaging techniques that have matured into a large integrated field enveloped within various branches of science (Figure 1.1) [2]. In the area of modern-day imaging where technology is at its pinnacle, molecular design still holds a dominant role in the forefront of molecular imaging.
Figure 1.1 Types of multidisciplinary fields related to molecular imaging.
In the past, developments in contrast agents, probes, and dyes have brought about an era of creativity where new techniques, materials, and designs have flourished to form a concrete foundation resulting in today's achievements in diagnosis and therapy (Figure 1.2). The construction of better chemical molecules will continue to help us develop a more comprehensive picture of learning about life science. Figure 1.3depicts a timeline in the development of the field [1-3].
Figure 1.2 Diagram showing the links in the design rationale of imaging agents.
Figure 1.3 An approximate timeline showing the development of the different imaging modalities [1-3].
Positron Emission Tomography (PET) is a nuclear medicine tomographic modality and one of the most sensitive methods for quantitative measurement of physiologic processes in vivo [4]. This technique utilises positron-emitting radionuclides and requires the use of radiotracers that decay and produce two 511 keV ?-rays resulting from the annihilation of a positron and an electron. One of the most commonly used molecules is 18 F-labelled fluorodeoxyglucose (18FDG), which has radioactive fluorine and is readily taken up by tumours (Figure 1.4) [5].
Figure 1.4 18FDG, a typical contrast agent used in PET.
In PET, a neutron-deficient isotope causes positron annihilation to produce two 511 keV ?-rays, which are simultaneously emitted when a positron from a nuclear disintegration annihilates in tissue. PET imaging, unlike MRI, ultrasound, and optical imaging, does not require any external sources for probing or excitation; instead, the source is generated from radioisotopes and emitted from but not transmitted through an object/patient, as in CT imaging [4-7]. Radionuclides are incorporated as part of a small metabolically active molecule to generate radiotracers such as 18FDG, which are then intravenously injected into patients at trace dosage for PET imaging. 18FDG is a favourable radiotracer because it is inhibited from metabolic degradation before it decays due to the fluorine at the 2' position in the molecule. Upon decay, the fluorine is converted into 18O. There is generally a short period of time before accumulation of radiotracers into the targeted organs or tissues that are being examined, so it is important for radiotracers to have a suitable half-life-some commonly used radionuclei have very short half-lives. Some common radionuclides used in PET are 11-C (half-life ~20 min), 13-N (~10 min), 15-O (~2 min) and 18-F (~110 min). These are produced by a cyclotron, whereas 82-Rb (76 s), which is used in clinical cardiac PET, is produced by a generator [8-9].
When a radioisotope undergoes positron emission decay (positive ß-decay), it emits a positron that travels through the tissue for a short distance (~ < 2 mm) whilst decelerating by the loss of its kinetic energy until it collides with an electron. This results in back-to-back annihilation of ?-ray photons, which move in opposite directions and are emitted nearly 180 degrees apart before being detected by scintillators and a photomultiplier tube. This type of coincidence is a true coincidence event; to detect this, the detectors are designed like a ring that surrounds the patient during the scanning procedure. Several parallel rings form the complete detection panel of the PET system in a cylindrical geometry (Figure 1.5).
Figure 1.5 Typical configuration of a PET scanner.
PET has relatively high sensitivity in detecting molecular species (10-11 - 10-12 M), even though not all annihilation photons are used for image reconstruction because not all coincidences are true coincidences. A coincidence event is assigned to a line of response where the two relevant detectors are joined (detectors opposite to each other); this allows for positional information to be located from the detected radiation without any physical collimators. This is known as electronic collimation. There are four types of coincidence events in PET: true, scattered, random, and multiple (Figure 1.6). Only true coincidence, which is the simultaneous detection of two emissions from a single annihilation event, is useful. No other events are detected within this coincidence time-window.
Figure 1.6 Different types of coincidence events.
Scattered coincidence occurs when one or both photons from a single event are scattered and both are detected; however, one of the photons must have undergone at least one Compton scattering event prior to detection. This type of event adds a background to the true coincidence event and causes overestimation of the isotope concentration as well as decreasing image contrast. In Compton scattering, a photon interacts with an electron in the absorber material, resulting in an increase in the kinetic energy of the electron as well as a change in direction in the photon. The energy of the photon after interaction is defined as:
where E is the energy of the incident photon, E´ is the energy of the scattered photon, m0c2 is the rest mass of the electron, and q is the scattering angle [10]. From Equation 1.1, it can be seen that fairly large deflections can occur with just a small loss of energy; for example, for 511 keV photons, a Compton scattering event results in a deflection of over 25 degrees but results in just a 10% loss in the photon energy. Random coincidence is the simultaneous detection of emission from more than one decay event. It occurs when two photons not arising from the same annihilation event are incident on the detectors within the coincidence time-window of the system. This contributes to statistical noise in data as well as overestimation of isotope concentration [8].
Multiple coincidences occur when more than two photons are detected by different detectors within the coincidence resolving time. This type of event either causes event mis-positioning or rejection because it is not possible to determine the line of response to which the event should be assigned. Coincidence events are grouped together to produce projection images called sonograms. Acquisition of PET images is not a simple process because data corrections are required for scattered, random coincidences as well as for the effects of attenuation, because the data acquired from the PET camera are given as projections. The measured projections are different from the projections assumed in image reconstruction [9]. Reconstruction of images from projections is computationally burdensome. Data reconstruction and correction are usually carried out by analytical or iterative methods. Analytical methods are simple, fast, and usually have predictable linear...
Dateiformat: ePUBKopierschutz: Adobe-DRM (Digital Rights Management)
Systemvoraussetzungen:
Das Dateiformat ePUB ist sehr gut für Romane und Sachbücher geeignet – also für „fließenden” Text ohne komplexes Layout. Bei E-Readern oder Smartphones passt sich der Zeilen- und Seitenumbruch automatisch den kleinen Displays an. Mit Adobe-DRM wird hier ein „harter” Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.Bitte beachten Sie: Wir empfehlen Ihnen unbedingt nach Installation der Lese-Software diese mit Ihrer persönlichen Adobe-ID zu autorisieren!
Weitere Informationen finden Sie in unserer E-Book Hilfe.